XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Capital in Excess of Par [Member]
Treasury Stock [Member]
Retained Earnings (Accumulated Deficit) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2020 $ 304,561 $ 278 $ 277,539 $ (24,919) $ (23,502) $ 2,012 $ 231,408 $ 73,153
Balance, shares at Dec. 31, 2020   27,828,871   (2,951,243)        
Net income 9,071       8,431   8,431 640
Distributions to non-controlling interest (1,511)             (1,511)
Stock-based compensation expense 498 $ 2 496       498  
Issuance of restricted stock, net, shares   163,561            
Forfeiture of restricted stock, net, shares   (7,602)            
Exercise of stock options, shares   768            
Other comprehensive (loss) income, net of tax (605)         (605) (605)  
Ending balance at Mar. 31, 2021 312,014 $ 280 278,035 $ (24,919) (15,071) 1,407 239,732 72,282
Ending balance, shares at Mar. 31, 2021   27,985,598   (2,951,243)        
Balance at Dec. 31, 2020 304,561 $ 278 277,539 $ (24,919) (23,502) 2,012 231,408 73,153
Balance, shares at Dec. 31, 2020   27,828,871   (2,951,243)        
Net income 37,386              
Other comprehensive (loss) income, net of tax (719)              
Ending balance at Sep. 30, 2021 338,612 $ 280 279,454 $ (24,919) 11,136 1,293 267,244 71,368
Ending balance, shares at Sep. 30, 2021   28,033,404   (2,951,243)        
Balance at Dec. 31, 2020 $ 304,561 $ 278 277,539 $ (24,919) (23,502) 2,012 231,408 73,153
Balance, shares at Dec. 31, 2020   27,828,871   (2,951,243)        
Exercise of stock options, shares [1] 44,070              
Net change in unrealized gains (losses) on investments, net of tax $ (1,000)              
Ending balance at Dec. 31, 2021 $ 355,828 $ 281 280,038 $ (24,919) 30,606 1,034 287,040 68,788
Ending balance, shares at Dec. 31, 2021 25,173,386 28,124,629   (2,951,243)        
Balance at Mar. 31, 2021 $ 312,014 $ 280 278,035 $ (24,919) (15,071) 1,407 239,732 72,282
Balance, shares at Mar. 31, 2021   27,985,598   (2,951,243)        
Net income 11,592       10,267   10,267 1,325
Distributions to non-controlling interest (1,511)             (1,511)
Stock-based compensation expense 576   576       576  
Issuance of restricted stock, net, shares   15,514            
Forfeiture of restricted stock, net, shares   (10,332)            
Exercise of stock options 116   116       116  
Exercise of stock options, shares   22,227            
Net change in unrealized gains (losses) on investments, net of tax 27         27 27  
Ending balance at Jun. 30, 2021 322,814 $ 280 278,727 $ (24,919) (4,804) 1,434 250,718 72,096
Ending balance, shares at Jun. 30, 2021   28,013,007   (2,951,243)        
Net income 16,724       15,940   15,940 784
Distributions to non-controlling interest (1,512)             (1,512)
Stock-based compensation expense 602   602       602  
Forfeiture of restricted stock, net, shares   (678)            
Exercise of stock options 125   125       125  
Exercise of stock options, shares   21,075            
Other comprehensive (loss) income, net of tax (141)              
Net change in unrealized gains (losses) on investments, net of tax (141)         (141) (141)  
Ending balance at Sep. 30, 2021 338,612 $ 280 279,454 $ (24,919) 11,136 1,293 267,244 71,368
Ending balance, shares at Sep. 30, 2021   28,033,404   (2,951,243)        
Balance at Dec. 31, 2021 $ 355,828 $ 281 280,038 $ (24,919) 30,606 1,034 287,040 68,788
Balance, shares at Dec. 31, 2021 25,173,386 28,124,629   (2,951,243)        
Net income $ 11,353       9,841   9,841 1,512
Distributions to non-controlling interest (1,512)             (1,512)
Stock-based compensation expense 598 $ 4 594       598  
Issuance of restricted stock, net, shares   383,925            
Forfeiture of restricted stock, net, shares   (5,730)            
Exercise of stock options $ 152   152       152  
Exercise of stock options, shares 23,192 [1] 23,192            
Purchase of common stock (in Shares)       (67,660)        
Purchase of common stock $ (617)     $ (617)     (617)  
Dividend paid on common stock (2,044)       (2,044)   (2,044)  
Other comprehensive (loss) income, net of tax (1,717)         (1,717) (1,717)  
Ending balance at Mar. 31, 2022 362,041 $ 285 280,784 $ (25,536) 38,403 (683) 293,253 68,788
Ending balance, shares at Mar. 31, 2022   28,526,016   (3,018,903)        
Balance at Dec. 31, 2021 $ 355,828 $ 281 280,038 $ (24,919) 30,606 1,034 287,040 68,788
Balance, shares at Dec. 31, 2021 25,173,386 28,124,629   (2,951,243)        
Net income $ 35,312              
Other comprehensive (loss) income, net of tax (4,596)              
Net change in unrealized gains (losses) on investments, net of tax 4,600              
Ending balance at Sep. 30, 2022 $ 359,889 $ 285 282,681 $ (43,741) 55,438 (3,562) 291,101 68,788
Ending balance, shares at Sep. 30, 2022 23,185,070 28,529,993   (5,344,923)        
Balance at Mar. 31, 2022 $ 362,041 $ 285 280,784 $ (25,536) 38,403 (683) 293,253 68,788
Balance, shares at Mar. 31, 2022   28,526,016   (3,018,903)        
Net income 14,811       13,300   13,300 1,511
Distributions to non-controlling interest (1,511)             (1,511)
Stock-based compensation expense $ 863   863       863  
Issuance of restricted stock, net, shares   4,944            
Forfeiture of restricted stock, net, shares   587            
Exercise of stock options, shares [1] 0              
Purchase of common stock (in Shares)       (1,272,150)        
Purchase of common stock $ (9,974)     $ (9,974)     (9,974)  
Dividend paid on common stock (1,971)       (1,971)   (1,971)  
Other comprehensive (loss) income, net of tax (1,418)         (1,418) (1,418)  
Ending balance at Jun. 30, 2022 362,841 $ 285 281,647 $ (35,510) 49,732 (2,101) 294,053 68,788
Ending balance, shares at Jun. 30, 2022   28,530,373   (4,291,053)        
Net income 9,148       7,636   7,636 1,512
Distributions to non-controlling interest (1,512)             (1,512)
Stock-based compensation expense $ 1,034   1,034       1,034  
Forfeiture of restricted stock, net, shares   (380)            
Exercise of stock options, shares [1] 0              
Purchase of common stock (in Shares)       (1,053,870)        
Purchase of common stock $ (8,231)     $ (8,231)     (8,231)  
Dividend paid on common stock (1,930)       (1,930)   (1,930)  
Other comprehensive (loss) income, net of tax (1,461)         (1,461) (1,461)  
Net change in unrealized gains (losses) on investments, net of tax 1,500              
Ending balance at Sep. 30, 2022 $ 359,889 $ 285 $ 282,681 $ (43,741) $ 55,438 $ (3,562) $ 291,101 $ 68,788
Ending balance, shares at Sep. 30, 2022 23,185,070 28,529,993   (5,344,923)        
[1] The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was $0 and less than $0.1 million for the three and nine months ended September 30, 2022 and was $0.2 million for the year ended December 31, 2021.